289 related articles for article (PubMed ID: 30008472)
1. Rectal Cancer in 2018: A Primer for the Gastroenterologist.
Goldenberg BA; Holliday EB; Helewa RM; Singh H
Am J Gastroenterol; 2018 Dec; 113(12):1763-1771. PubMed ID: 30008472
[No Abstract] [Full Text] [Related]
2. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Benson AB; Venook AP; Al-Hawary MM; Cederquist L; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Engstrom PF; Grem JL; Grothey A; Hochster HS; Hoffe S; Hunt S; Kamel A; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Mulcahy MF; Murphy JD; Nurkin S; Saltz L; Sharma S; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Wuthrick E; Gregory KM; Gurski L; Freedman-Cass DA
J Natl Compr Canc Netw; 2018 Jul; 16(7):874-901. PubMed ID: 30006429
[TBL] [Abstract][Full Text] [Related]
3. Management of Locoregional Rectal Cancer.
Willett CG
J Natl Compr Canc Netw; 2018 May; 16(5S):617-619. PubMed ID: 29784739
[TBL] [Abstract][Full Text] [Related]
4. Evolving Treatment Paradigm in the Treatment of Locally Advanced Rectal Cancer.
Smith CA; Kachnic LA
J Natl Compr Canc Netw; 2018 Jul; 16(7):909-915. PubMed ID: 30006431
[TBL] [Abstract][Full Text] [Related]
5. Seminal Vesicle Adherent to Rectal Wall Following Neoadjuvant Chemoradiotherapy: A Potential False-Positive Diagnostic Pitfall.
Liaquat S; Idowu MO; Hatfield BS
Int J Surg Pathol; 2020 Jun; 28(4):406-409. PubMed ID: 32008384
[TBL] [Abstract][Full Text] [Related]
6. Assessment of T and N staging with MRI
Xu L; Zhang Z; Qin Q; Zhang C; Sun X
J Int Med Res; 2020 Jun; 48(6):300060520928685. PubMed ID: 32495710
[TBL] [Abstract][Full Text] [Related]
7. Avoidance of Overtreatment of Rectal Cancer by Selective Chemoradiotherapy: Results of the Optimized Surgery and MRI-Based Multimodal Therapy Trial.
Ruppert R; Kube R; Strassburg J; Lewin A; Baral J; Maurer CA; Sauer J; Junginger T; Hermanek P; Merkel S;
J Am Coll Surg; 2020 Oct; 231(4):413-425.e2. PubMed ID: 32697965
[TBL] [Abstract][Full Text] [Related]
8. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
9. Rectal NETs and rectosigmoid junction NETs may need to be treated differently.
Cai W; Ge W; Hu H; Mao J
Cancer Med; 2020 Feb; 9(3):971-979. PubMed ID: 31840409
[TBL] [Abstract][Full Text] [Related]
10. Lateral lymph node dissection for low rectal cancer: Is it necessary?
Christou N; Meyer J; Toso C; Ris F; Buchs NC
World J Gastroenterol; 2019 Aug; 25(31):4294-4299. PubMed ID: 31496614
[TBL] [Abstract][Full Text] [Related]
11. Extramural spread of rectal cancer and the AJCC Cancer Staging Manual 8th edition, 2017.
Nicholls RJ; Zinicola R; Haboubi N
Ann Oncol; 2019 Aug; 30(8):1394-1395. PubMed ID: 31046085
[No Abstract] [Full Text] [Related]
12. Do We Have to Treat All T3 Rectal Cancer the Same Way?
Valadão M; Dias JA; Araújo R; Cesar D
Clin Colorectal Cancer; 2020 Dec; 19(4):231-235. PubMed ID: 32839078
[TBL] [Abstract][Full Text] [Related]
13. Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer.
Park JS; Park SY; Kim HJ; Cho SH; Kwak SG; Choi GS
Dis Colon Rectum; 2019 Apr; 62(4):408-416. PubMed ID: 30688680
[TBL] [Abstract][Full Text] [Related]
14. Tumor budding for predicting prognosis of resected rectum cancer after neoadjuvant treatment.
Demir A; Alan O; Oruc E
World J Surg Oncol; 2019 Mar; 17(1):50. PubMed ID: 30871581
[TBL] [Abstract][Full Text] [Related]
15. [Advances of optimized neoadjuvant therapy in the treatment of locally advanced rectal cancer].
Fan J; Zhu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):527-533. PubMed ID: 31238633
[TBL] [Abstract][Full Text] [Related]
16. Rectal cancer.
Legoux JL; Lehur PA; Penna C; Calais G; Roseau G; Calan LD
Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S43-2S51. PubMed ID: 17151562
[No Abstract] [Full Text] [Related]
17. Tweaking the TNM Language for Rectal Cancer: A Slippery Slope.
Greene FL
Dis Colon Rectum; 2015 Jun; 58(6):617-8. PubMed ID: 25944435
[No Abstract] [Full Text] [Related]
18. Pathologic complete response implies a fewer number of lymph nodes in specimen of rectal cancer patients treated by neoadjuvant therapy and total mesorectal excision.
Bustamante-Lopez LA; Nahas CSR; Nahas SC; Marques CFS; Pinto RA; Cotti GC; Imperiale AR; de Mello ES; Ribeiro U; Cecconello I
Int J Surg; 2018 Aug; 56():283-287. PubMed ID: 29981939
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant Therapy for Rectal Cancer.
Leeds IL; Fang SH
Dis Colon Rectum; 2018 Aug; 61(8):883-886. PubMed ID: 29994956
[TBL] [Abstract][Full Text] [Related]
20. Application value of biplane transrectal ultrasonography plus ultrasonic elastosonography and contrast-enhanced ultrasonography in preoperative T staging after neoadjuvant chemoradiotherapy for rectal cancer.
Xiao Y; Xu D; Ju H; Yang C; Wang L; Wang J; Hazle JD; Wang D
Eur J Radiol; 2018 Jul; 104():20-25. PubMed ID: 29857861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
